article thumbnail

Global pharmaceutical manufacturer arriving in South Australia

Manufacturer's Monthly

Global pharmaceutical company, Noumed, has made groundbreaking construction towards its $100 million pharmaceutical manufacturing facility at Salisbury, creating 250 construction jobs and 180 ongoing jobs upon completion.

article thumbnail

Using Sensors & IoT for Pharmaceutical Manufacturing

ATS

Share Pharmaceutical manufacturing operations are challenging environments for asset maintenance. IoT in pharmaceutical manufacturing supports predictive maintenance strategies that lower costs while raising OEE. is an enabler of customized manufacturing. Referencing the Industry 4.0 Industry 4.0

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Creating intelligence in the pharmaceutical supply chain.

Manufacturing & Logistics IT

Covid-19 is straining supply chains around the world, most notably those of pharmaceutical companies. Scarcity of raw materials upstream and overheated demand downstream cause disruptions. Control over their supply chain is a major challenge for all pharma companies today.

article thumbnail

EU regulation lacks consideration of pharmaceutical industry emissions

E&T

The study has described the current regulation of pharmaceutical companies as being unable to prevent the release of chemicals into the environment throughout the manufacturing supply chain. Moreover, in the EU, it is not possible to refuse the marketing authorisation of human pharmaceuticals based on environmental reasons.

article thumbnail

Fusion Pharmaceuticals provides manufacturing update

Canadian Manufacturing

HAMILTON and BOSTON — Fusion Pharmaceuticals Inc., 4 that it has completed validation of its good manufacturing practice (GMP) manufacturing facility and produced the first clinical dose of a TAT. “We achieved alignment with the U.S. . “We achieved alignment with the U.S. ” Fusion reported on Jan.

article thumbnail

Fusion Pharmaceuticals to be acquired by AstraZeneca

Canadian Manufacturing

HAMILTON and BOSTON — Fusion Pharmaceuticals Inc., Fusion Pharmaceuticals says that RCs have emerged as a promising modality in cancer treatment over recent years. The acquisition brings manufacturing and supply chain capabilities in actinium-based RCs to AstraZeneca. It also strengthens their presence in Canada.

article thumbnail

Fusion Pharmaceuticals to open radiopharmaceutical manufacturing facility to produce targeted alpha therapies for cancer

Canadian Manufacturing

Photo: Fusion Pharmaceuticals. HAMILTON — Fusion Pharmaceuticals Inc., a clinical-stage oncology company focused on developing radiopharmaceuticals as precision medicines, announced the opening of its radiopharmaceutical manufacturing facility. At full capacity, it is expected to produce over 100,000 doses of TATs per year.